A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT03009344 · COMPLETED
Trial details
- NCT number
- NCT03009344
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2017-07-12
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.